Founded to serve health, Servier is a global group governed by a Foundation that aspires to have a meaningful social impact, both for patients and for a sustainable world.
As a world leader in cardiology, Servier's ambition is to become a focused and innovative player in oncology by targeting hard-to-treat cancers. Neuroscience and immuno-inflammatory diseases are the future growth drivers. In all these areas, the Group includes the patient voice at each stage of the life cycle of a medicine.
Servier relies on a strong geographical footprint in over 150 countries